After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
Clinical Trials Arena on MSN
PDS Biotech’s stock up on colorectal cancer trial success
PDS Biotech has released data from the Phase II investigator-led colorectal cancer trial.
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a ...
Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimental drugs ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...
Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...
Biotech held steady in early 2026 as M&A buyouts and rotation from the Magnificent Seven lifted IBB relative strength—read ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results